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Background: Advancement in endovascular techniques has led to rapid growth in endovas-
cular revascularization, and it has emerged as a treatment for critical limb ischemia (CLI).
Clinical effectiveness of revascularization has been frequently judged by vessel patency and
limb salvage, but there is paucity of reports on outcomes of the wound. We present a
retrospective analysis of immediate angiographic and 3-month clinical outcome of patients
who underwent endovascular reconstruction of popliteal and infrapopliteal arteries for CLI.
Methods: All patients who underwent endovascular reconstruction of popliteal and/or
infrapopliteal arteries for CLI and >70% stenosis on digital subtraction angiography between
March 2010 and November 2014 and had a clinical follow-up of at least 3 months were
selected for analysis.
Results: 34 patients underwent endovascular reconstruction. 9 patients (26%) underwent
only POBA and remaining 25 (74%) underwent additional stenting. 13 patients (38%) had
multiple segmental revascularization. 24 patients (71%) had successful vessel recanaliza-
tion. Linear ﬂow to foot in at least one artery could be achieved in 20 patients (59%) post
revascularization. Successful wound healing occurred in 11 (35%) patients with an additional
7 (21%) patients showing clinical improvement in their wounds. Limb salvage was achieved
in 33 patients (97%) at 3-month follow-up.
Conclusion: Endovascular revascularization of popliteal and infrapopliteal arteries is a fea-
sible, safe, and effective procedure for the treatment of CLI. Normal inﬂow and outﬂow with
at least one of the three infrapopliteal vessels being patent is essential for adequate healing
of chronic ulcers and prevention of major amputation.
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patients.
Variable Study subjects (n = 34)
Age
40–60 15 (44%)
61–75 16 (47%)
>75 3 (09%)
Men 22 (65%)
Women 12 (35%)
Diabetes mellitus 33 (97%)
Smoking 2 (06%)
Coronary artery disease 8 (24%)
LV dysfunction 3 (09%)
Baseline high creatinine (>1.3 mg%) 9 (26%)
Rest pain 3 (09%)
Ulcer 31 (91%)
Gangrenous ulcer 9 (26%)
Prior toe amputation 8 (24%)1. Introduction
Critical limb ischemia (CLI) occurs, when arterial blood ﬂow to
the part or entire foot is markedly reduced, in most cases as a
result of progressive obstructive atherosclerosis.1 Although
surgical bypass has long been considered the gold standard
treatment for CLI patients, its use is limited by absence of
suitable conduits, advanced age, and presence of comorbid-
ities, resulting in high morbidity and mortality rates.2
Advancement in endovascular techniques and technology
has led to rapid growth in endovascular revascularization of
popliteal, tibial, peroneal, and pedal arteries, and it has
emerged as a treatment for CLI secondary to popliteal and
infrapopliteal artery stenosis/occlusion.3 Clinical effectiveness
of endovascular revascularization has been frequently judged
by vessel patency and limb salvage, but still there is a paucity
of reports on outcomes of the wound.1 We present a
retrospective analysis of immediate angiographic and 3-
month clinical outcome of patients who underwent endovas-
cular reconstruction of popliteal and infrapopliteal arteries for
CLI.
2. Methods
All patients who underwent endovascular reconstruction of
popliteal and/or infrapopliteal arteries for CLI and >70%
stenosis on digital subtraction angiography between March
2010 and November 2014 and had a clinical follow-up of at
least 3 months were selected for analysis. CLI was deﬁned as
>2 weeks of rest pain or ulcer/gangrene attributable to
peripheral arterial disease. Serum creatinine value was
determined before and after the procedure. A nephroprotec-
tion protocol was used in all nondialyzed patients with
baseline creatinine above 1.3 mg% (N-acetylcysteine 600 mg
twice a day and Trimetazidine 35 mg twice a day, both given
orally for 5 days). Patients were preloaded with 600 mg of
clopidogrel, 60 mg of prasugrel, or 180 mg of ticagrelor 1 h prior
to the procedure.
Percutaneous transluminal angioplasty (PTA) was per-
formed under local anesthesia through contralateral puncture
of the common femoral artery, and vascular access was
accomplished using 7 F Introducer Sheath (Cordis Corporation,
Florida, USA). If obstructions were present at duplex scanning
in the contralateral iliac or common femoral artery, the arterial
puncture was performed through an antegrade puncture of
ipsilateral common femoral artery. 7500 U bolus of heparin
was administered intra-arterially at the beginning of the
procedure and ACT was maintained above 250 s. A double
length (300 cm; Cougar XT, Medtronic USA) 0.014-in. guide wire
was used to cross the lesion.
PTA was performed with standard angioplasty balloons
(2–15 cm in length; 2–10 mm in diameter) selected to match
the length of the lesion and the diameter of the artery. Balloon
size selection was based on the visual estimate of the size of
the vessel. Balloon inﬂation pressures ranged from 4 to 16
atmospheres and were repeated routinely two to three times
(for at least 60 s) at the same segment. A variety of balloon
catheters (Maverick Monorail-Boston Scientiﬁc, Ireland;Admiral xTreme – Invatec, Italy; and Amphirion Deep –
Invatec, Italy) were used.
Stents used were either bare metal stents (BMS) (Prozeta PS,
Vascular Concepts, Bangalore, India) and drug eluting stents
(DES) (Pronova, Vascular Concepts, Bangalore, India; Biomime
Aura, Meril, Brussels, Belgium), or self expanding stents
(Complete SE, Medtronic Inc, Minneapolis, USA). All poplite-
al/infrapopliteal lesions were stented only if >30% residual
stenosis or ﬂow limiting dissection occurred following plain
balloon angioplasty and associated inﬂow (ileal/femoral)
lesions were also stented.
Dual oral antiplatelet therapy with aspirin (150 mg/day)
and clopidogrel (75 mg/day), prasugrel (10 mg/day) or ticagre-
lol (90 mg/day) was continued long term (at least 1 year) and
the duration of treatment was life-long for aspirin.
Vessel recanalization was considered successful when
direct ﬂow was obtained in the treated vessel, with no
signiﬁcant residual stenosis along the whole artery. Wound
healing was considered successful when the index wound got
completely healed within 3-month follow-up. In patients
presenting with rest pain without foot ulcer, the disappear-
ance of pain was considered limb salvage successful. In
patients with foot ulcers, we considered limb salvage
successful when the plantar stand was maintained, even
when achieved by a tarsal-metatarsal amputation. Any above-
the-ankle amputation was considered a failure.
3. Results
34 patients underwent endovascular reconstruction of popli-
teal and infrapopliteal arteries for CLI between March 2010 and
November 2014 (Table 1). Mean age was 65 years (range 43–84
years) and majority (97%) had diabetes. 8 patients (24%) had
coronary artery disease, and 3 (09%) had associated LV
dysfunction (LVEF <40%). 31 patients (91%) had an ulcer,
while 3 patients (9%) presented with rest pain.
Obstructions of >70% of vessel diameter were present in
the infrapopliteal arteries in all patients except two (n = 32,
94%). 15 patients (44%) had lesions affecting all 3 infrapopliteal
Table 2 – Segmental location of lesions.
Segmental location No. of patients
n = 34 (%)
Exclusively in infrapopliteal arteries 13 (38%)
Exclusively in popliteal artery 2 (06%)
Popliteal and infrapopliteal arteries 9 (27%)
Femoropopliteal and infrapopliteal arteries 10 (29%)
Table 3 – Number of segments treated.
No. of segments treateda No. of patients
n = 34 (%)
One 21 (62%)
Two 10 (29%)
Three 3 (09%)
a Femoral, popliteal, and/or infrapopliteal segments.
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patients (44%), and femoral lesions were present in 10 (29%)
patients (Table 2). Two patients had lesions conﬁned to the
popliteal artery. 26 patients (76%) had occlusive lesions and 20
occlusions (39%) had lesion length >100 mm. 19 patients (56%)
had calciﬁc vessels. 8 patients (24%) had diffusely diseased
plantar arch.
3.1. Endovascular revascularization
9 patients (26%) underwent only plain old balloon angioplasty
(POBA). Remaining 25 patients (74%) underwent stenting; 19
(76%) of whom had dissection of the artery while 6 (24%) had
>30% residual stenosis post POBA. 10 patients (40%) who
underwent stenting required POBA for revascularization of
other segments.
13 patients (38%) had multiple segmental revascularization
(Table 3). Details of location of lesions, proportion of patients
who underwent endovascular revascularization, and success-
ful vessel recanalization achieved in individual arteries are
shown in Table 4. Overall 44 stents were deployed: 22 in
infrapopliteal, 13 in popliteal, and 9 stents in femoral arteries.
Majority (26 stents, 59%) were DES, 3 (7%) were BMS, and 15
(34%) were self expanding stents. 24 patients (71%) had
successful vessel recanalization in all treated arteries follow-
ing endovascular revascularization. Linear ﬂow to foot in at
least one infrapopliteal artery could be achieved in 20 patients
(59%) post revascularization.Table 4 – Endovascular revascularization and successful vesse
Artery No. of patients Endovascular reva
Superﬁcial femoral 10 8 (8
Popliteal 17 17 (1
Anterior tibial 24 17 (7
Tibioperoneal 8 3 (3
Posterior tibial 24 11 (4
Peroneal 17 3 (1
Dorsalis pedis 2 2 (13.2. Endovascular revascularization for femoral lesions
All 10 patients who had associated lesions in femoral segment
underwent revascularization to improve inﬂow. 8 patients
(80%) underwent successful PTA and stenting. All (n = 9) were
self-expandable stents. Remaining 2 patients (20%) underwent
femoropopliteal bypass surgery with Gore-Tex graft as a part
of hybrid revascularization.
3.3. Endovascular revascularization for popliteal lesions
All 17 patients with popliteal lesions underwent endovascular
revascularization with successful vessel recanalization. 5
patients (29%) underwent POBA and 12 patients (71%) under-
went stenting. 4 patients had lesions involving mid (P 2)
segment, behind knee joint of which 2 underwent stenting and
remaining 2 underwent POBA. 7 DES and 6 self expanding
stents were deployed in popliteal artery.
3.4. Endovascular revascularization for infrapopliteal
lesions
Out of 32 patients with infrapopliteal lesions, 25 patients (78%)
underwent endovascular revascularization for infrapopliteal
lesions. 15 patients (60%) had successful vessel recanalization.
In remaining 10 patients (40%), linear ﬂow to the foot could not
be established post revascularization due to distal diffuse
disease despite revascularization in proximal segments of
same vessel.
14 patients (54%) underwent stenting of which 2 underwent
across ankle joint (1 in dorsalis pedis and 1 in distal posterior
tibial artery). 5 patients (36%) had additional POBA done. 11
patients (44%) had only POBA as their revascularization mode.
19 DES and 3 BMS were deployed in infrapopliteal arteries.
15 patients (44%) had lesions in all 3 infrapopliteal arteries.
In this subset, establishment of uninterrupted ﬂow to foot in at
least one vessel (Fig. 1) was achieved in 9 patients (61%), two
vessels in 2 patients (13%), and all three in 1 patient (7%). In 1
patient (7%), in spite of revascularization, linear ﬂow could not
be achieved at the foot due to diffusely diseased distal anterior
tibial artery. In remaining 2 patients (13%), only popliteal and
femoral endovascular revascularization was done in view of
totally occluded and diffusely diseased infrapopliteal vessels;
one patient also had associated renal dysfunction.
In 6 patients with single vessel runoff, 4 (67%) underwent
successful revascularization to index vessel with reestablish-
ment of linear ﬂow to foot.l recanalization in individual arteries.
scularization (%) Successful vessel recanalization (%)
0%) 8 (100%)
00%) 17 (100%)
1%) 12 (71%)
7%) 1 (33%)
6%) 6 (55%)
8%) 2 (67%)
00%) 2 (100%)
Fig. 1 – (a) Complete occlusion of all 3 infrapopliteal arteries
in a patient with CLI. (b) Linear flow to the foot in at least
one infrapopliteal artery (anterior tibial artery) after PTA.
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lesions (Table 5) were treated by endovascular revasculariza-
tion. 2 patients underwent femoropopliteal grafting as a part of
hybrid revascularization. Only 7 infrapopliteal occluded
lesions (18%) were treated by endovascular revascularization
(Fig. 2). Majority of the infrapopliteal occluded lesions could
not be opened in view of calciﬁc long segment occlusions and
distal diffuse disease; nevertheless, linear ﬂow to the foot was
maintained by opening up nonoccluded, stenotic parallel
artery or via naturally patent parallel artery.
Of the 9 patients with high baseline creatinine, creatinine
stabilized without dialysis in 7 patients. 2 were already on
hemodialysis. 1 patient, who had a normal creatinine before
procedure had a transient rise in creatinine after PTA requiring
hemodialysis temporarily. In the absence of complications,
hospital stay was 3 days.
3.5. Clinical follow-up at 3 months
Wound care with debridement and regular dressings post
revascularization were sufﬁcient to achieve successful wound
healing in 11 (35%) patients with an additional 7 (21%) patients
showing clinical improvement in their wounds. 12 (39%)Table 5 – Outcome of occluded lesions.
Superﬁcial
femoral
artery (n = 4)
Popliteal
artery
(n = 8)
Ante
tibial a
(n = 
POBA 3 (38%) 1 (9%
PTA + Stent 2 (50%) 5 (62%) 1 (9%
Hybrid 2 (50%)
Unable to cross wire 3 (25
Medical management 7 (57patients had to undergo planned amputation. 11 had minor
amputations (9 had toe amputation and 2 had trans metatarsal
amputation) and one had major amputation (below knee). All
minor amputations were performed 2–7 days (mean of 3 days)
after index PTA out of which 8 (73%) were having preexisting
gangrene and rest 3 (27%) had intractable local infection. The
patient who underwent major amputation (45 days after PTA)
had persistent nonhealing gangrenous ulcer with diffusely
diseased infrapopliteal arteries and only popliteal lesion could
be successfully tackled. One patient had persistent nonhealing
ulcer but had good ﬂow up to dorsalis pedis on arterial doppler
at 3 months; he had uncontrolled diabetes mellitus. 2 patients
underwent skin grafting. Resolution of ischemic rest pain
occurred in all 3 patients who presented with rest pain. Limb
salvage was achieved in 33 patients (97%) at 3-month follow-
up.
4. Discussion
With the increasing prevalence of diabetes mellitus and
greater life expectancy, the incidence of peripheral artery
disease, especially CLI is progressively rising.4 CLI is an
advanced disease marked by the development of rest pain,
ischemic ulceration, or gangrene and is associated with a high
amputation and mortality rate.5 CLI generally occurs in
diabetics with extensive atherosclerotic disease of the be-
low-the-knee vessels. Most have associated lesions in iliac,
femoral, and popliteal arteries.6 Even with aggressive local
wound care, patients who do not undergo revascularization
often progress to amputation with the likelihood of amputa-
tion increasing as the ankle-brachial index decreases.7 In
patients who do not undergo an attempt at revascularization,
CLI caused major amputation in 73% of the patients with rest
pain and in 95% of the patients with tissue loss at 1 year.8 The
optimal treatment for CLI is prompt revascularization, but
careful planning is required, as patients often have multilevel
disease and limited options for revascularization.9
Preventing major amputation in CLI is arguably the most
important goal and is predicated on the ability to restore and
maintain linear arterial ﬂow to the foot.10 For that the inﬂow
consisting of iliofemoral arteries and outﬂow via the popliteal
and at least one infrapopliteal artery should be near normal
along with a healthy plantar arch. Options for revasculariza-
tion include surgery, endovascular intervention, and 'hybrid
therapy' – a combination of surgical and endovascular therapy.
In our series of 34 patients with CLI, majority (56%) had
lesions affecting multiple segments of which 68% underwentrior
rtery
12)
Tibioperoneal
artery (n = 3)
Posterior
tibial artery
(n = 16)
Peroneal
artery (n = 8)
) 2 (12%)
) 2 (67%) 1 (6%)
%) 1 (6%)
%) 1 (33%) 12 (76%) 8 (100%)
Fig. 2 – Endovascular revascularization performed for posterior tibial artery with multiple stenosis and occlusions. (a and b)
Multiple stenosis and occlusions of posterior tibial artery. (c) Angioplasty with 2.5 mm T 120 mm long balloon (Amphirion
Deep – Invatec, Italy). (d) Angioplasty with 2.5 mm T 15 mm balloon (Maverick Monorail-Boston Scientific, Ireland). (e) Post
angioplasty showed good flow without residual stenosis/flap. (f) Plantar arch flow maintained via posterior tibial artery.
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lesions were successfully opened; 2 required hybrid therapy as
inﬂow lesions were not amenable for endovascular revascu-
larization. Majority (59%) of our patients achieved linear ﬂow
to the foot in at least one artery following endovascular
revascularization. Ideally all lesions in outﬂow need to be
addressed, but may not be feasible in all patients due to
associated comorbidities such as renal insufﬁciency and/or LV
dysfunction. Only femoropopliteal lesions were tackled in 3 of
our patients due to associated comorbidities. Diffuse disease
and long segment chronic total occlusions also limit complete
revascularization.
The optimal strategy for infrapopliteal disease has not been
clearly deﬁned. 1-year restenosis rate after balloon angioplasty
of long lesions in below-the-knee arteries may be as high as
70%.11 Given its safety and clinical effectiveness, balloon
angioplasty is generally preferred as a standard treatment for
patients with infrapopliteal disease.12 As a suboptimal (or
‘‘bail-out’’) treatment, stent implantation is currently reserved
for some cases, such as signiﬁcant recoil, ﬂow-limiting
dissection, or residual stenosis after balloon angioplasty.4 In
our series, 54% had stenting done for infrapopliteal lesions
after PTA. Recently, with the advancement in stent material
and design, primary bare metal stent and drug-eluting stent
implantation have been used as an alternative therapy to treat
infrapopliteal disease in selected patients.10,13 Drug eluting
balloons are increasingly being used, but could not be used in
our patients as it was not commercially available during studyperiod. Drug-eluting balloons compared with PTA strikingly
reduced 1-year restenosis (27% versus 74%), target lesion
revascularization (18 versus 43%), and target vessel occlusion
(17% versus 55%) in the treatment of below-the-knee lesions in
diabetic patients with CLI.12
In a recent study involving popliteal lesions, provisional
stenting as part of a plain balloon angioplasty strategy was
found to have equivalent 1-year patency (67.4% versus
65.7%).14 In our series, out of 17 patients, 12 (71%) underwent
stenting in the popliteal artery after PTA.
An attempt at a foot salvage procedure should take place
after a revascularization procedure has been performed if
possible.15 The level of adequate circulation, extent of
infection, if any, and remaining function of the foot are
factors considered when choosing the level of a foot salvage
procedure. A waiting period of at least 3 days has been
suggested; this allows for sufﬁcient time for the restoration of
perfusion and for demarcation to occur.15 All minor amputa-
tions in our series were performed as part of foot salvage
procedure and were done at a mean of 3 days after index PTA.
O'Brien-Irr et al. in their analysis of 106 infrainguinal
interventions for CLI reported wound healing rate of 50% with
a mean healing time of 7 months.16 78% of patients who
achieved prompt healing did so by 2 months. Limb salvage was
83% at 2 years in patients with tissue loss. This was
comparable to our results; successful healing of the index
wound occurred in 35% of patients (additional 21% showing
clinical improvement) with a limb salvage rate of 97% at 3
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in wound healing rates between studies is complicated by
differences in patient mix, local wound care standards, wound
duration prior to intervention, etc.2
In the presence of CLI, limb salvage depends on successful
revascularization.17 The goal of acute treatment is to perfuse
the ischemic limb and allow healing.6 Additional perfusion is
necessary to heal the ulcer, but once it heals, the skin viability
can be maintained even though the treated artery gets re-
occluded.18 Also slow restenosis of the treated artery allows
time to form new collateral circulation.19 When no pain is
present or wound healing has occurred in CLI patients, a
possible delayed closure of the treated vessel may not always
be clinically relevant.20 If restenosis of the treated lesion
occurs at a later date, the wound generally will not recur in the
absence of recurrent injury.6 Similarly amputation is not
synonymous with failure of revascularization; in some,
revascularization is performed with the aim of limiting the
extent of amputation and promoting wound healing after
amputation.21
5. Conclusion
Endovascular revascularization of popliteal and infrapopli-
teal arteries is a feasible, safe, and effective procedure for the
treatment of CLI. Immediate angiographic outcome was good
and 3-month wound healing/limb salvage rates were high.
Despite advances in management of wound care (growth
factors and novel approaches to stimulating wound healing),
management of vascular disease in patients with CLI is an
important consideration. Normal inﬂow and outﬂow with at
least one of the three infrapopliteal vessels being patent are
essential for adequate healing of chronic ulcers and
prevention of major amputation. Associated comorbidities
may hamper complete revascularization. The need for a
multidisciplinary team to provide good foot care is also
essential.
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